Policy in focus: Is psilocybin the next cannabis?
Canadian Medical Association Journal November 14, 2021 Greg Basky 7 citations
Interest in using psilocybin (the active compound in 'magic mushrooms') for therapy is increasing, while unregulated dispensaries selling psychedelics proliferate in Canada and the United States. Over the past ten years, research into the clinical application of psychedelics for conditions such as depression and addiction has undergone a revival.